DiaMedica Therapeutics Inc. has granted stock options to five new non-executive employees who joined the company in August and September 2025. The options allow the purchase of a total of 490,000 shares of DiaMedica's common stock at an exercise price of $6.76 per share, matching the closing price on September 18, 2025. The options vest with 25% becoming exercisable on the one-year anniversary of the grant date, and the remaining 75% vesting in twelve equal quarterly installments over the following three years. The options have a ten-year term.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DiaMedica Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250929761357) on September 29, 2025, and is solely responsible for the information contained therein.